Marine lipids as building blocks for soft quaternary ammonium compounds and their antibacterial activity

Pharmazie

Volumn 59, Issue 5, 2004, Pages 360-364

  Loftsson, Thorsteinn ^a   Thorsteinsson, T ^a   Masson M ^a  

^a UNIVERSITY OF ICELAND   (Iceland)

Author keywords

[No Author keywords available]

Indexed keywords

BENZALKONIUM CHLORIDE; CETYLPYRIDINIUM SALT; LIPID; MARINE LIPID; QUATERNARY AMMONIUM DERIVATIVE; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; CONFERENCE PAPER; DRUG DEGRADATION; DRUG DESIGN; DRUG HALF LIFE; DRUG STABILITY; HUMAN; LIPOPHILICITY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; STAPHYLOCOCCUS AUREUS; STRUCTURE ACTIVITY RELATION;

ADMINISTRATION, CUTANEOUS; ANIMALS; ANTI-BACTERIAL AGENTS; HALF-LIFE; LETHAL DOSE 50; LIPIDS; MARINE BIOLOGY; MICE; MICROBIAL SENSITIVITY TESTS; QUATERNARY AMMONIUM COMPOUNDS; STAPHYLOCOCCUS AUREUS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 2642572752     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (28)

1. Agharkar S, Lindenbaum S, Higuchi T (1976) Enhancement of solubility of drug salts by hydrophilic counterions: properties of organic salts of an antimalarial drug. J Pharm Sci 65: 747-749.
2. Ahlström B, Thompson RA, Edebo L (1999a) The effect of hydrocarbon chain length, pH, and temperature on the binding and bactericidal effect of amphiphilic betaine esters on Salmonella typhimurium. APMIS 107: 318-324.
3. Ahlström B, Thompson RA, Edebo L (1999b) Loss of bactericidal capacity of long-chain quaternary ammonium compounds with protein at lowered temperature. AMPMIS 107: 606-614.
4. Ariëns EJ (1980) Design of safer chemicals. In: Ariëns EJ (ed.) Design of safer chemicals Book, Academic Press, New York.p. 1-46.
5. Bodor N (1984) The soft drug approach. Chemtech 14(1): 28-38.
6. Bodor N (1997) Retrometabolic approaches for drug design and targeting. Pharmazie 52: 491-494.
7. Bodor N, Kaminsky JJ, Selk S (1980) Soft drugs. 1. Quaternary ammonium salts of soft antimicrobials. J Med Chem 23: 469-474.
8. Calvani M, Critelli L, Gallo G, Giorgi F, Gramiccioli G, Santaniello M, Scafetta N, Tinti MO, Angelis FD (1998) L-Carnitine esters as "soft", broad-spectrum antimicrobial amphiphiles. J Med Chem 41: 2227-2233.
9. Devinsky F, Masárová M, Lacko I, Mlynarcik D (1991) Structure-activity relationships of "soft" quaternary ammonium amphiphiles. J Biopharm Sci 2: 1-10.
10. Devinsky F, Zamocka J, Lacko I, Polakovicova M (1996) QSAR and CAMM study of amphiphilic antimicrobially active 2,2′-bipyridyl monoammonium salts. Pharmazie 51: 727-731.
11. Kabara JJ, Vrable R, Lie Ken Jie MSF (1977) Antimicrobial lipids: natural and synthetic fatty acids and monoglycerides. Lipids 12: 753-759.
12. Levy SB (1998) The challenge of antibiotic resistance. Scientific American 278(3): 32-39.
13. Loftsson T, Gudmundsdóttir TK, Friöriksdóttir H, Sigurdardóttir AM, Thorkelsson J, Guömundsson G, Hjaltason B (1995) Fatty acids from cod-liver oil as skin penetration enhancers. Pharmazie 50: 188-190.
14. Loftsson T, Gunnarsdóttir T, Magnússon LM, Friöriksdóttir H, Guömundsdóttir TK, Ólafsson JH, Haraldsson GG, Guömundsson G, Hjaltason B (1997a) Effects of various marine lipids on transdermal drug delivery - in vitro evaluation. Boll Ch Farm 136: 640-645.
15. Loftsson T, Thormar H, Hjalmarsdóttir M (1997b) Unpublished results.
16. Loftsson T, Thormar H, Ólafsson JH, Gunnarsdóttir TM, Hjaltason B, Guömundsson G (1998) Fatty acid extract from cod-liver oil: activity against herpes simplex virus and enhancement of transdermal delivery of acyclovir in-vitro. Pharm Pharmacol Commun 4: 287-291.
17. Másson M, Loftsson T, Haraldsson GG (2000a) Marine lipids for prodrugs, soft compounds and other pharmaceutical applications. Pharmazie 55: 172-177.
18. Másson M, Thorsteinsson T, Sigurdsson TH, Loftsson T (2000b) Lipophilic metronidazole derivatives and their absorption through hairless mouse skin. Pharmazie 55: 369-371.
19. McMurry LM, Oethinger M, Levy SB (1998) Triclosan targets lipid synthesis. Nature 394: 531-532.
20. Thorgeirsdóttir TO, Thormar H, Kristmundsdóttir T (2003) Effects of polysorbates on antiviral and antibacterial activity of monoglyceride in pharmaceutical formulations. Pharmazie 58: 286-287.
21. Thormar H, Isaacs CE, Brown HR, Barshatzky MR, Pessolano T (1987) Inactivation of enveloped viruses and killing of cells by fatty acids and monoglycerides. Antim Agents Chemother 31: 27-31.
22. Thorsteinsson T, Másson M, Loftsson T, Haraldsson GG, Stefansson E (1999) Diacyl glyceryl ester prodrugs for slow release in the skin: synthesis and in vitro degradation and absorption studies for naproxen derivatives. Pharmazie 54: 831-836.
23. Thorsteinsson T, Másson M, Loftsson T (2000) Dermal delivery of ETH-615, a zwitterionic drug. Drug Devel Ind Pharm 26: 709-714.
24. Thorsteinsson T, Másson M, Loftsson T, Nevalainen T, Järvinen T (2002) Cyclocerine fatty acid derivatives as prodrugs: synthesis, degradation and in vitro skin permeability. Chem Pharm Bull 50: 554-557.
25. Thorsteinsson T, Loftsson T, Masson M (2003a) Soft antibacterial agents. Curr Med Chem 10: 1129-1136.
26. Thorsteinsson T, Másson M, Kristinsson KG, Hjá lmarsdóttir MA, Hilmarsson H, Loftsson T (2003b) Soft antimicrobial agents: synthesis and activity of labile environmental friendly long chain quaternary ammonium compounds. J Med Chem 46: 4173-4181.
27. Tsutsumi K, Obata Y, Takayama K, Loftsson T, Nagai T (1998a) Effect of cod-liver oil extract on the buccal permeation of ergotamine tartrate. Drug Devel Ind Pharm 24: 757-762.
28. Tsutsumi K, Obata Y, Takayama K, Loftsson T, Nagai T (1998b) Effect of the cod-liver oil extract on the buccal permeation of ionized and nonionized forms of ergotamine using the keratinized epithelial-free membrane of hamster cheek pouch mucosa. Int J Pharm 174: 151-156.